Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.

Journal of acquired immune deficiency syndromes (1999) - 1 Oct 2013

Hamers Raph L, Zaaijer Hans L, Wallis Carole L, Siwale Margaret, Ive Prudence, Botes Mariette E, Sigaloff Kim C E, Hoepelman Andy I M, Stevens Wendy S, Rinke de Wit Tobias F

Abstract excerpt

BACKGROUND: This study assessed HIV-hepatitis B virus (HBV) coinfection in southern Africa in terms of prevalence, viral characteristics, occult HBV, and the effect of lamivudine- versus tenofovir-containing first-line combination antiretroviral treatment (cART) on HBV-related outcomes. METHODS: A multicenter prospective cohort of HIV-infected adults in Zambia and South Africa who initiated cART. Outcomes by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenine
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Coinfection

Share to Lamivudine

Share to Organophosphonates

Share to South Africa

Share to Tenofovir

Share to Zambia

Source

Identifiers

PMID: 23892239
DOI: 10.1097/QAI.0b013e3182a60f7d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes.PMID 23892239Read ↗

Prevalence and Genotypic Characterization of HBV in HIV-Infected Patients from Kwazulu-Natal, South AfricaSemantic proximity Read ↗

Low risk of lamivudine-resistant HBV and hepatic flares in treated HIV-HBV-coinfected patients from Côte d'Ivoire.Semantic proximity Read ↗

Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon.Semantic proximity Read ↗

Epidemiology of HBV infection in a cohort of Ugandan HIV-infected patients and rate and pattern of lamivudine-resistant HBV infection in patients receiving antiretroviral therapy.Semantic proximity Read ↗

Prevalence and Genotypic Characterization of Hbv In Hiv- Infected Patients From Kwazulu-Natal, South AfricaSemantic proximity Read ↗

A systematic review of Hepatitis B virus (HBV) drug and vaccine escape mutations in Africa: a call for urgent actionSemantic proximity Read ↗

HBV infection in untreated HIV-infected adults in Maputo, Mozambique.Semantic proximity Read ↗

A Review of Human Immunodeficiency Virus and Hepatitis B Virus Co-Infection in Botswana.Semantic proximity Read ↗

HBV genotypes and drug resistance mutations in antiretroviral treatment-naive and treatment-experienced HBV-HIV-coinfected patients.Semantic proximity Read ↗

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM).Semantic proximity Read ↗

Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa.Semantic proximity Read ↗

High Prevalence of Hepatitis B Virus Drug Resistance Mutations to Lamivudine Among People with HIV/HBV Coinfection in Rural and Peri-Urban Communities in BotswanaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.